119-HR-3164 Journalist Public Summary
119 · HR 3164 Ensuring Community Access to Pharmacist Services Act
A bipartisan House bill would let Medicare Part B pay pharmacists for certain basic testing and treatment—like flu, COVID‑19, RSV, and strep visits—and for services tied to federally declared public‑health emergencies, with payment rules pegged to the physician fee schedule. It aims to make quick, local care easier to get, especially where clinics are scarce, while raising questions about costs and coordination.
Public Summary
Headline Summary: Let Medicare pay pharmacists for certain basic testing and treatment so people can get quick care at local pharmacies.
What It Does: The Ensuring Community Access to Pharmacist Services Act (H.R. 3164) adds “pharmacist services” to Medicare Part B for limited conditions—office‑style visits and related tests/treatments for COVID‑19, influenza, RSV, and strep throat—and for services tied to a federally declared public‑health emergency. Pharmacists must operate within what their state allows and, where required, in collaboration with a physician or other qualified practitioner. Medicare would pay using the physician fee schedule (generally at 85% of the physician rate; 100% when addressing a declared public‑health need). Balance billing by pharmacists would be barred. The policy would start January 1, 2026.
- Who’s For It: Bipartisan House sponsors led by Rep. Adrian Smith (R‑NE) with co‑leads Reps. Brad Schneider (D‑IL), Diana Harshbarger (R‑TN), and Doris Matsui (D‑CA).
- Community and independent pharmacies that want to offer quick, local care for common illnesses and public‑health needs.
- Rural health and access‑to‑care advocates who see pharmacies as close‑to‑home entry points for timely treatment.
- Some patient groups who favor shorter wait times and expanded testing/treatment options.
- Who’s Against It: Some physician organizations may worry about fragmented care or scope‑of‑practice creep if more services move outside traditional clinics.
- Budget hawks and some insurers may raise concerns about added Medicare spending if new billable visits increase overall utilization.
- Skeptics of state‑by‑state rules may point to uneven availability, since what a pharmacist can do still depends on each state’s laws.
What’s Next: A House committee advanced the bill by voice vote on May 21, 2026. The next steps are a written committee report and potential House floor consideration, followed by Senate action if it passes the House. If both chambers pass it in the same form, it would go to the President.
Discussion